Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial

Volume: 27, Issue: 2, Pages: 709 - 720
Published: Nov 11, 2019
Abstract
Calcitriol, the active metabolite of vitamin D, is an essential regulator in the hematopoiesis and immunity. However, knowledge revealing its influence on the immune and hematologic reconstitution after hematopoietic stem cell transplantation (HSCT) in clinical trials is very limited.The effects of calcitriol on short-term and long-term hematopoietic recovery, relapse-free survival (RFS) and overall survival (OS) in multiple myeloma, Hodgkin's...
Paper Details
Title
Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial
Published Date
Nov 11, 2019
Volume
27
Issue
2
Pages
709 - 720
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.